Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

By eter, L. E, Ipsky, Esiree, M. M.F., Van Der, Eijde, Aniel, F. E., Urst and 19 more. New England Journal of Medicine, 2000

3,098 citations recorded by the source corpus.

Subfields: Hematology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/50c63446fe99b1a92aa39943a997767dd2872a91

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. F. Balkwill

In Rheumatology

1. P. Tak
2. Lars Klareskog
3. D. Tracey
4. J. Salfeld
5. E. Sasso
6. M. Feldmann
7. F. Balkwill

Citations in the corpus

• Development of anti-TNF therapy for rheumatoid arthritis (2002, background): “These results of combination therapy with anti-TNF antibody plus methotrexate in the long-term Phase II study were replicated in a Phase III stud”
• Binding and functional comparisons of two types of tumor necrosis factor antagonists. (2002, background): “, Malvern, PA) (Targan et al., 1997; Maini et al., 1999; Lipsky et al., 2000) and etanercept (Enbrel; Immunex, Seattle, WA) (Moreland et al.”